Table 1.
Demographic and Smoking Variables for all Subjects for Study 1 (n = 30) and by Medication Group for Study 2 (n = 62)
| M (SD) or n (%) | Study 1 | Study 2 | ||
| All subjects (n = 30) | Placebo (n = 21) | Varenicline (n = 20) | Bupropion (n = 21) | |
| Age | 31.93 (10.29) | 36.47 (10.95) | 34.95 (11.36) | 34.95 (9.70) |
| Female | 15 (50) | 9 (42.9) | 9 (45) | 8 (38) |
| Race/ethnicitya | 16C, 11AA, 3H | 13C, 5AA, 0H | 10C, 6AA, 1H | 15C, 4AA, 1H |
| Education (% high school) | 16 (53) | 10 (47.6) | 12 (60) | 8 (38.1) |
| Yearly family income | $25,689 ($24,765) | $34,078 ($30,586) | $26,617 ($18,894) | $39,047 ($25,068) |
| Cigarettes per day | 16.67 (6.38) | 19.16 (7.61) | 16.62 (5.85) | 16.86 (6.06) |
| FTNDb | 5.13 (1.70) | 5.76 (2.70) | 5.05 (1.79) | 5.76 (2.10) |
| Smoke within 5 min of wakingc | 2 (6.7) | 10 (46.7) | 8 (40) | 9 (42.9) |
| Baseline breath CO (ppm) | 25.03 (13.32) | 25.76 (10.60) | 22.95 (13.24) | 21.38 (8.99) |
| Contemplation ladderd | 3.76 (2.50) | 5.00 (2.81) | 4.59 (2.62) | 5.45 (2.21) |
Note. aRace: (C) Caucasian, (AA) African American, (H) Hispanic.
b
FTND: Fagerström Test of Nicotine Dependence (range 1–10; Heatherton et al., 1991).
c
FTND-item 1.
d
Range 1–10.